Provided by Tiger Trade Technology Pte. Ltd.

SeaStar Medical Holding Corporation

0.3400
+0.02608.28%
Post-market: 0.3299-0.0101-2.97%18:20 EST
Volume:6.60M
Turnover:2.13M
Market Cap:12.26M
PE:-0.17
High:0.3400
Open:0.3200
Low:0.3015
Close:0.3140
52wk High:3.07
52wk Low:0.2900
Shares:36.05M
Float Shares:33.83M
Volume Ratio:0.76
T/O Rate:19.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0246
EPS(LYR):-6.6327
ROE:-290.37%
ROA:-86.54%
PB:1.07
PE(LYR):-0.05

Loading ...

SeaStar Medical Holding Corporation to Release Third Quarter Financial Results

Reuters
·
Nov 05

Nanny's Negligence Leads to Infant Suffocation: Parents Demand 160,000 Yuan Compensation

Deep News
·
Oct 29

Reviving Lives and Building Health Barriers: The Life Ark at the Foot of Mount Gongga in Sichuan

Deep News
·
Oct 24

ICU Medical Is Maintained at Overweight by Keybanc

Dow Jones
·
Oct 21

Harmonic Inc Showcases Fiber Breakthroughs at Network X 2025

Reuters
·
Oct 09

‘Something doesn’t smell right’: $100 million in Skills Development Fund grants traced to lobbyists with ties to Ontario premier

Bloomberg
·
Oct 07

SeaStar Medical Holding Corp - Board Restores Directors' Cash Retainer Fees - SEC Filing

THOMSON REUTERS
·
Sep 30

SeaStar Medical Holding - Increases Salaries of CEO Eric Schlorff & Cmo Kevin Chung - SEC Filing

THOMSON REUTERS
·
Sep 30

SeaStar Medical Restores Executive Salaries and Board Retainers After Cost-Cutting Measures

Reuters
·
Sep 30

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

TIPRANKS
·
Sep 29

SeaStar Medical Announces Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury at International Symposium

Reuters
·
Sep 29

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

TIPRANKS
·
Sep 25

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

TIPRANKS
·
Sep 25

SeaStar Medical Announces DSMB-Backed Continuation and Expanded Enrollment of Pivotal NEUTRALIZE-AKI Trial for Acute Kidney Injury Therapy

Reuters
·
Sep 25

SeaStar Medical Unveils Early SAVE Registry Data on QUELIMMUNE for Pediatric Acute Kidney Injury at International Symposium

Reuters
·
Sep 23

Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104

GlobeNewswire
·
Sep 18

ICU Medical Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Sep 10

Seastar Medical Files Initial Beneficial Ownership Statement for Bradford K Towne, Principal Accounting Officer

Reuters
·
Sep 10

SeaStar Medical Holding Corporation to Participate in HC Wainwright 27th Annual Global Investment Conference

Reuters
·
Sep 05

SeaStar Medical Announces Significant Cost Savings and Improved Survival Rates with QUELIMMUNE Therapy for Pediatric AKI in Newly Published Study

Reuters
·
Sep 02